PNKP and cancer: Since the inhibiting PNKP activity is an important target for anticancer drugs, in addition to the inhibition of phosphatase and kinase enzymatic activity (Freschauf et al., 2009), inhibiting phosphorylation at T118 of PNKP might be a potent target for cancer therapy.